New Mission, New Website coming soon! Learn more now.

Equities logo
Close this search box.

Immunovaccine’s DepoVax™ Continues to Play a Pivotal Role in the Future of Modern Medicine

With its innovative DepoVax™ platform, Immunovaccine is quickly emerging as a leading name in the immunotherapy and cancer vaccine space of the life sciences sector.
NASH is a tremendous opportunity for biotech/drug developers as the potential market could be in the tens of billions.